Full-length IL-33 contributes to pulmonary fibrosis in a receptor-independent manner, [8,9,10,11], and based on the data presented in this report, ST2 regulates the fibrotic response independently of the presence or absence of IL-33. The gene discussed is IL33; the disease is pulmonary fibrosis.